ForViva (LON:FVA – Get Free Report) issued its quarterly earnings results on Wednesday. The company reported GBX 11 earnings per share (EPS) for the quarter, Digital Look Earnings reports. The business had revenue of GBX 5,057 million for the quarter.
ForViva Stock Performance
Shares of FVA traded up GBX 1.50 during mid-day trading on Wednesday, reaching GBX 128. The stock had a trading volume of 66,660 shares, compared to its average volume of 53,607. The firm has a market capitalization of £66.29 million and a price-to-earnings ratio of 5.59. ForViva has a 12 month low of GBX 114.50 and a 12 month high of GBX 140. The business’s fifty day moving average price is GBX 129.36.
Wall Street Analyst Weigh In
A number of analysts have weighed in on FVA shares. Canaccord Genuity Group restated a “buy” rating and set a GBX 190 price objective on shares of ForViva in a research note on Friday, March 20th. Shore Capital Group restated a “hold” rating on shares of ForViva in a research report on Friday, April 17th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, ForViva presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 190.
About ForViva
ForViva plc (LON: FVA) is a United Kingdom–based property company that operates in the residential and specialist housing sectors. The group’s activities are focused on ownership, management and leasing of housing assets that serve social, affordable and supported living needs. Its portfolio is oriented toward providing long‑term rental accommodation and specialist premises that accommodate people requiring additional care or support.
Services associated with ForViva’s property portfolio typically include day‑to‑day asset management, tenancy management, property maintenance and refurbishment, and collaboration with public sector bodies and third‑party care providers to deliver supported housing solutions.
Featured Stories
Receive News & Ratings for ForViva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ForViva and related companies with MarketBeat.com's FREE daily email newsletter.
